azulene has been researched along with Leukemia, Myeloid, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CN; Chang, MH; Chang, YL; Chen, CH; Chen, TS; Chen, YC; Chiou, SJ; Chou, NT; Chou, SH; Chuang, MY; Hseu, TH; Hsu, HC; Hsu, YL; Hu, TL; Hwang, CS; Ko, CH; Lai, CP; Lee, O; Lin, CL; Lin, HC; Lin, MW; Liu, CC; Liu, CP; Shih, YC; Sun, CY; Tsai, YJ; Tseng, HW; Tu, CM; Wang, LM; Wen, YF; Yang, WH; Yao, CN | 1 |
1 other study(ies) available for azulene and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Novel azulene-based derivatives as potent multi-receptor tyrosine kinase inhibitors.
Topics: Animals; Antineoplastic Agents; Azulenes; Cell Line, Tumor; Cell Proliferation; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred BALB C; Mice, Nude; Rats; Receptor Protein-Tyrosine Kinases | 2010 |